Standout Papers

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers 2018 2026 2020 2023 256
  1. Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers (2018)
    Anu Sharma, Sumit K. Subudhi et al. Clinical Cancer Research

Immediate Impact

14 by Nobel laureates 5 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
6 intermediate papers

Works of Anu Sharma being referenced

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel

Author Peers

Author Last Decade Papers Cites
Anu Sharma 393 324 16 60 10 557
George Locke 335 186 10 68 9 532
Hyungjun Jeon 433 422 34 89 11 648
Karthik Dhatchinamoorthy 318 324 33 63 7 612
Sangeeta Kakoti 481 252 28 115 12 619
Endang Nuryadi 448 219 25 119 11 612
Eric Routhier 162 100 23 129 11 504
K Braham 281 145 59 121 8 589
Kijong Yi 201 155 35 114 12 560
Janice P. Dutcher 351 136 17 64 12 484
Nicolas Chuvin 254 228 15 30 10 465

All Works

Loading papers...

Rankless by CCL
2026